Gamma Knife Market Size, Share, Trends & Forecast

The Gamma Knife Market is expanding as healthcare providers increasingly adopt precise, non-invasive radiosurgery for neurological conditions and certain cancers. The market was valued at approximately USD 0.56 billion in 2024 and is projected to reach USD 0.59 billion in 2025 and USD 0.97 billion by 2035, registering a 5.2% CAGR from 2025 to 2035. Technological advances and growing demand for minimally invasive treatment options are supporting this growth.

By disease indication, brain metastasis currently represents the largest segment, reflecting the established use of Gamma Knife technology in targeted treatment of intracranial tumors. The cancer segment is experiencing faster growth as cancer incidence increases and precision treatment becomes more important. Arteriovenous malformation and trigeminal neuralgia also remain important clinical applications.

The head segment dominates the anatomy category, largely because Gamma Knife systems are widely used for brain tumors, vascular malformations, and other cranial conditions. The neck segment is developing as applications expand into selected head and neck conditions. Improved imaging and treatment-planning technologies are helping clinicians target affected areas with greater precision.

Technology is a major factor shaping the market. Advanced imaging, treatment-planning software, precision targeting, and AI-supported workflows are helping improve the accuracy and efficiency of stereotactic radiosurgery. The growing preference for non-invasive procedures, which can reduce recovery requirements compared with conventional surgery, is also contributing to adoption.

North America holds approximately 45% of the global market, followed by Europe at around 30%, while Asia-Pacific accounts for roughly 20% and is identified as the fastest-growing region. Expanding healthcare infrastructure, government investment, and increasing access to advanced cancer treatment are creating opportunities across emerging markets. Future growth is likely to come from improved imaging integration, AI-enabled treatment planning, localized treatment centers, and partnerships between healthcare providers and technology companies.